All In Biotech

Free tool

FAERS Monitor: Adrenalin

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 204200 or its brand name (Adrenalin, Epinephrine). Reports on generic versions are filed under their own applications.

Reports

42,905

Serious

26,807

62% of reports

Hospitalization

14,202

Death reported

3,624

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective4,582
  • headache3,085
  • sinusitis2,921
  • fatigue2,812
  • product dose omission issue2,782
  • pain2,498
  • covid-192,425
  • dyspnoea2,298
  • nausea2,239
  • off label use2,136
  • pneumonia2,081
  • inappropriate schedule of product administration1,786
  • nasopharyngitis1,684
  • pyrexia1,668
  • urinary tract infection1,593

Reports by year received

View as table
YearReports
2004135
2005118
2006136
2007166
2008194
2009275
2010267
2011706
2012431
2013342
2014444
2015673
20161,133
20171,654
20182,514
20193,369
20206,479
20213,953
20223,610
20233,814
20244,459
20254,763
20263,267

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,011,254 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
sinusitisSignal2,92114.413.935,411
covid-19Signal2,4256.96.612,058
inappropriate schedule of product administrationSignal1,7864.94.75,527
product dose omission issueSignal2,7824.74.58,063
urinary tract infectionSignal1,5934.64.44,497
nasopharyngitisSignal1,6844.54.34,596
pneumoniaSignal2,0813.23.03,107
headacheSignal3,0852.42.32,633
pyrexiaSignal1,6682.42.31,335
pain2,4982.01.91,276
dyspnoea2,2982.01.91,164
fatigue2,8121.81.7981
drug ineffective4,5821.71.71,425
nausea2,2391.41.3251
off label use2,1361.21.171

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.